Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope.
Andersen
R S
RS
Wenandy
L
L
Sørensen
R B
RB
thor Straten
P
P
Andersen
M H
MH
D000208:Acute Disease; D017951:Antigen Presentation; D017209:Apoptosis; D019496:Cancer Vaccines / Q000276:immunology*; D002277:Carcinoma / Q000097:blood / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology; D000939:Epitopes / Q000276:immunology*; D015789:HLA-A2 Antigen / Q000276:immunology*; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood / Q000276:immunology; D007951:Leukemia, Myeloid / Q000276:immunology / Q000473:pathology; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009363:Neoplasm Proteins / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000276:immunology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000276:immunology*; D037182:T-Cell Antigen Receptor Specificity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019139:Tumor Escape / Q000276:immunology; D014611:Vaccination